Clinical Trial Update: Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC [Phase 2]

View source ↗

Summary

Phase 2 trial update of iparomlimab and tuvonralimab with gemcitabine/cisplatin for advanced intrahepatic cholangiocarcinoma, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Fudan University | Conditions: Advanced Intrahepatic Cholangiocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING